Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001069530-20-000057)

Filing Details

Accession Number:: 0001069530-20-000057
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-09-17 17:25:33
Reporting Period:: 2020-09-17

Accepted Time:: 2020-09-17 17:25:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1069530	Cassava Sciences Inc	SAVA	Pharmaceutical Preparations (2834)	911911336

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1532303	Eric Schoen	C/O Cassava Sciences, Inc. 7801 N. Capital Of Texas Hwy.; Suite 260 Austin TX 78731	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-09-17	10,000	$7.03	25,300	No	4	P	Direct
Common Stock	Acquisiton	2020-09-17	2,000	$7.04	27,300	No	4	P	Indirect	Purchase by Schoen Family LLC. Reporting person is a member of the Schoen Family LLC.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	Purchase by Schoen Family LLC. Reporting person is a member of the Schoen Family LLC.

Footnotes

The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $7.01 to $7.04 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote.